Topper Copies

You are the Director of the National Bioethics Commission who is responsible for assessing the ethical feasibility and oversight of a nationwide gene sequencing program. The project named GeneFuture, aims to sequence the DNA of every newborn child and store it in a centralized national database. The objective is to identify genetic predispositions to serious diseases early in life, allowing for preventive treatment and personalized medicine. Over 100,000 babies have already been enrolled in the pilot phase of the program. The government claims that this move is a landmark step in public health advancement. However, collection of newborn genetic data raises significant ethical concerns, particularly around informed consent, which may not fully capture parents' understanding of the long-term risks involved. Once gathered, this sensitive data could be misused for purposes such as surveillance, insurance discrimination, or commercial marketing by third parties. Uncertainty over data ownership - whether it lies with the state, parents, or the individual as they mature - further complicates the issue. The involvement of private tech and pharmaceutical companies heightens fears of commercial exploitation, especially in the absence of clear mechanisms for individuals to withdraw consent or delete their genetic information upon reaching adulthood. (a) What are the ethical issues you perceive in the implementation of the GeneFuture program? (b) Identify the conflicting interests of different stakeholders in this case. (c) What guiding ethical principles would you recommend for implementation of this project?

Ishan Bhatnagar, AIR 5, 2025

This situation discloses the following stakeholders ->

(a) Ethical Issues

For Newborns - (i) absence of consent on their part (ii) potential of discrimination on insurance (iii) surveillance threat (iv) potential, future uncertainties

Parents -> absence of informed consent

Government (i) Respect for right to privacy (ii) means vs ends. (iii) data ownership (iv) surveillance state

Private Companies (i) misuse of data (ii) right to be forgotten

(b) Conflicting Interests

1. Newborns' right to privacy vs. societal interest in information on genetic basis of diseases. 2. Government's interest in information and data for guiding health policy vs. privacy of newborn 3. Pharmaceutical and Insurance interest in profit vs. through data (as new oil) vs. govt welfare interest & newborns' privacy interest

(c) The guiding principles would be inspired from GDPR of Europe and Oviedo Convention on Bioethics. They are as follows:

1. Data ownership with data principal, which is, the newborn child. 2. Right to rescind consent upon majority 3. Right to be forgotten 4. Principle of agency: government as agent of the people while managing their data. 5. Systemic propriety: incorruptible system where data cannot be stolen or used for other purposes. 6. Private sector Trusteeship: use data for common good. 7. Strict Accountability: breaches of purpose or use of data to be penalized 8. Demilited access: where a researcher wants to use the data, it shall be - (i) anonymized (ii) controlled viewing through e-discovery mechanisms (iii) for scientific use only.

Such measures will help us avoid "science without humanity", which is a sin as per Gandhiji.